Multicomponent collection (MCC) with the latest hemapheresis apparatuses

Area of Science:

• Blood banking and transfusion medicine
• Apheresis technology
• Hematology

Background:

• Multicomponent collection (MCC) enhances donor utilization and reduces blood transfusion costs.
• Total apheresis is a growing trend in blood banking, with increasing industry and physician involvement.
• Three new multicomponent collection apparatuses (MCS+, Trima, Excel-Pro) were introduced in 1998.

Purpose of the Study:

• To evaluate the performance of three new multicomponent collection (MCC) apparatuses.
• To compare their effectiveness in plateletapheresis.
• To assess their suitability for modern blood banking needs.

Main Methods:

• A review of all multicomponent collections performed in 1998 using MCS+, Trima, and Excel-Pro cell separators.
• Evaluation criteria included platelet yield, white blood cell (WBC) contamination, efficiency, platelet activation, and packed red blood cell (PBRC) product quality.

Main Results:

• The study compared the performance of the three machines, with detailed results presented in a table (not included in the abstract text).
• The quality and quantity of platelet products collected were found to be good.
• The cost of collection kits is offset when packed red blood cells (PRBC) or a second platelet unit is collected.

Conclusions:

• Multicomponent collection with the evaluated apparatuses is well-accepted by donors and personnel.
• No significant risks to donors were identified, apart from occasional citrate (ACD) reactions or vasovagal episodes.
• The new apparatuses provide good quality and quantity of platelet products, contributing to cost-effectiveness in blood banking.